Fonte: Journal Pharmacogenomics Pharmacoproteomics. Unidades: FCF, ICB
Assuntos: POLIMORFISMO, FARMACOCINÉTICA, TRANSPLANTE DE RIM
ABNT
ALVES, Camila et al. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response. Journal Pharmacogenomics Pharmacoproteomics, v. 5, n. 3, p. 1-16 art. 1000134, 2014Tradução . . Disponível em: https://doi.org/10.4172/2153-0645.1000134. Acesso em: 13 jul. 2024.APA
Alves, C., Felipe, C. R., Nishikawa, A. M., Salgado, P. de C., Fajardo, C. M., Silva Junior, H. T., et al. (2014). Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response. Journal Pharmacogenomics Pharmacoproteomics, 5( 3), 1-16 art. 1000134. doi:10.4172/2153-0645.1000134NLM
Alves C, Felipe CR, Nishikawa AM, Salgado P de C, Fajardo CM, Silva Junior HT, Pestana JOM, Zetchaku D, Spinelli G, Oliveira N, Hirata MH, Hirata RDC, Rodrigues AC. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2014 ; 5( 3): 1-16 art. 1000134.[citado 2024 jul. 13 ] Available from: https://doi.org/10.4172/2153-0645.1000134Vancouver
Alves C, Felipe CR, Nishikawa AM, Salgado P de C, Fajardo CM, Silva Junior HT, Pestana JOM, Zetchaku D, Spinelli G, Oliveira N, Hirata MH, Hirata RDC, Rodrigues AC. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2014 ; 5( 3): 1-16 art. 1000134.[citado 2024 jul. 13 ] Available from: https://doi.org/10.4172/2153-0645.1000134